|
Real-time Estimate
Tradegate
11:54:54 17/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 358.58 EUR | +0.70% |
|
-0.35% | +27.04% |
| 01:30pm | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
| 14/08 | Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
- Consensus Amgen Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
